Spots Global Cancer Trial Database for Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma
Official Title: Dose-finding Study of Lenalidomide as Maintenance Therapy in Multiple Myeloma After Allogeneic Stem Cell Transplantation
Study ID: NCT00778752
Conditions
Interventions
Study Description
Brief Summary: This study is a Phase I (non-randomized) study evaluating three dose-levels of Lenalidomide in patients after allogeneic stem cell transplantation, accomplished in two institutions (University Medical Center Hamburg-Eppendorf/ University Medical Center Heidelberg).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Universitätsklinikum Hamburg-Eppendorf, Hamburg, , Germany
Universitätsklinikum Heidelberg, Heidelberg, , Germany
Contact Details
Name: Nicolaus Kroeger, Prof. Dr.
Affiliation: University Medical Center Hamburg-Eppendorf, Germany
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
